Document Detail


Biomarker-guided treatment of congestive heart failure.
MedLine Citation:
PMID:  20653714     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
As more patients are diagnosed with heart failure each year, heart failure management has become a growing public health issue. The development of new therapies and effective implementation of existing therapies for heart failure remain a challenge. Biomarkers, such as natriuretic peptides, offer consistent and cost-effective means of monitoring response to therapy. There is growing interest in using biomarkers to guide heart failure therapy due to their objectivity, reproducibility, and accessibility. There have been several trials to date, including the New Zealand Natriuretic Peptide-Guided Heart Failure Therapy study, the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure Studies, the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death trial, and the Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure trial, that examined the effectiveness of biomarker-guided heart failure therapy with very promising results. When compared with intensive medical management, natriuretic peptide-guided heart failure therapy was shown to be noninferior in general and slightly superior in certain patient populations. Although larger trials are required to validate their results, these studies have provided evidence for the effectiveness of biomarker-guided heart failure therapy and paved the way for the integration of biomarkers into routine evaluation and management of patients with heart failure.
Authors:
Yang Xue; Jeffrey Chan; Sonal Sakariya; Alan Maisel
Related Documents :
2894494 - Detrimental haemodynamic effects of cyclizine in heart failure.
11739814 - Hypotension and cognitive impairment: selective association in patients with heart fail...
17303764 - A role for caspase-1 in heart failure.
5904984 - Occurrence of lymphopenia in heart failure.
21251634 - Incidence, predictors, management, immediate and long-term outcomes following grade iii...
7930264 - Enhanced thrombolysis, reduced coronary reocclusion and limitation of infarct size with...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Congestive heart failure (Greenwich, Conn.)     Volume:  16 Suppl 1     ISSN:  1751-7133     ISO Abbreviation:  Congest Heart Fail     Publication Date:  2010 Jul 
Date Detail:
Created Date:  2010-07-26     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9714174     Medline TA:  Congest Heart Fail     Country:  United States    
Other Details:
Languages:  eng     Pagination:  S62-7     Citation Subset:  IM    
Affiliation:
University of California San Diego UCSD Medical Center, San Diego, CA 92103-8411, USA. yaxue@ucsd.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Use of BNP and bioimpedance to drive therapy in heart failure patients.
Next Document:  Diuretic management in heart failure.